Related Experiment Video
Updated: Jul 13, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors
Benjamin Lefkove1, Baskaran Govindarajan, Jack L Arbiser
1Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA. benjaminlefkove@hotmail.com
Abstract:
Fumagillin is an active amebicide and anti-infective isolated from the fungus Aspergillus fumigatus. Since its characterization in 1951, fumagillin has been studied extensively for its anti-infective properties. Although fumagillin is not approved for systemic use in the USA, this compound has one of the highest efficacies for the treatment of microsporidial infections in HIV-positive patients. Fumagillin does exhibit some side effects that have deterred its acceptance as a viable treatment, but the current body of research on the synthesis of novel analogs of this molecule shows an exciting and promising revival of this drug as both an anti-infective and antiangiogenic agent.
Insights
Fumagillin, an anti-infective from Aspergillus fumigatus, shows high efficacy against microsporidial infections, particularly in HIV-positive patients. Research into novel analogs suggests a promising revival for its anti-infective and antiangiogenic applications.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Fumagillin, isolated from Aspergillus fumigatus, is a potent amebicide and anti-infective agent.
- Despite its efficacy, fumagillin's systemic use is not approved in the USA due to side effects.
- It demonstrates high efficacy in treating microsporidial infections in HIV-positive individuals.
Purpose of the Study:
- To review the anti-infective and antiangiogenic properties of fumagillin.
- To highlight the potential of novel fumagillin analogs in drug development.
- To discuss the revival of fumagillin as a therapeutic agent.
Main Methods:
- Literature review of fumagillin's properties and analog synthesis.
- Analysis of efficacy data for microsporidial infections.
- Evaluation of antiangiogenic potential.
Main Results:
- Fumagillin exhibits significant anti-infective activity, especially against microsporidia.
- Novel analogs are being synthesized, showing promise for improved therapeutic profiles.
- The compound possesses notable antiangiogenic properties.
Conclusions:
- Fumagillin remains a compound of interest for its anti-infective capabilities.
- Ongoing research into fumagillin analogs suggests potential for new therapeutic applications.
- Fumagillin is a promising candidate for both anti-infective and antiangiogenic therapies.
Related Concept Videos
Mechanism of Angiogenesis
Antifungal Agents
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
